The Efficacy and Adverse Events in Patients with Head and Neck Cancer Following Radiotherapy Combined with S-1 Therapy: A Meta-Analysis

SIMPLE SUMMARY: Head and neck squamous cell carcinoma (HNSCC) ranks sixth among the most common cancers, accounting for approximately 3.3% of all cancer cases. While HNSCC was generally treated with postoperative concurrent chemo-radiotherapy, traditional chemotherapy agents often lead to multiple s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Hung-Sheng, Jhou, Hong-Jie, Ou, Yang-Hao, Liu, Yen-Tze, Kor, Chew-Teng, Chen, Andy Wei-Ge, Chen, Mu-Kuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231857/
https://www.ncbi.nlm.nih.gov/pubmed/34199326
http://dx.doi.org/10.3390/cancers13122971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231857/
https://www.ncbi.nlm.nih.gov/pubmed/34199326
http://dx.doi.org/10.3390/cancers13122971

Ejemplares similares